发明名称 THERAPEUTIC FRAGMENTS OF VON WILLEBRAND FACTOR
摘要 An aqueous solution of cysteine-altered von Willebrand Factor fragment which is substantially free of aggregate and capable of therapeutic use for treating thrombosis and a process for prepari ng such a solution comprising: (A) providing an aqueous solution of the fragment and denaturant; (13) purifying the solution of fragment and denaturant under conditions which promote conversion of aggregated forms of the fragment to the dimeric and/or monomer ic forms thereof to provide purified fragment; (C) separating the dissolved; purified fragment from the denaturant while maintaining the aqueous solution of the fragment at a pH of about 2.5 to less than about 5.5 to increase monomerization of, and decrease aggregation of, said purified fragment, thereby forming an aqueous solution of fragment which is substantially free of aggregate.
申请公布号 CA2110585(C) 申请公布日期 2004.10.12
申请号 CA19922110585 申请日期 1992.06.19
申请人 RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. 发明人 HRINDA, MICHAEL E.;FARB, DAVID L.;LEE, TED C.K.;PRIOR, CHRISTOPHER P.
分类号 A61K38/00;C07K1/113;C07K14/755;(IPC1-7):C07K14/745;A61K38/36;C07K1/107;C07K1/18 主分类号 A61K38/00
代理机构 代理人
主权项
地址